wegovy tirzepatide - Search News

Order byBest matchMost fresh

People lost more weight on Zepbound than Wegovy

This drug led to 50% more weight loss than Wegovy in head-to-head study

After 72 weeks, participants receiving the Zepbound injections lost an average of 50 pounds, or 20% of their body weight.

Study Finds on MSN · 23h

Weight Loss Showdown: Mounjaro (Tirzepatide) Trounces Wegovy in Head-to-Head Trial

· 1d

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs

· 1d

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 22h

First head-to-head trial found Zepbound beats Wegovy for weight loss

· 1d

New study compares Wegovy and Zepbound for the first time

· 1d

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Participants who took Eli Lilly’s tirzepatide, which is sold as Zepbound, lost 50 pounds on average, while those using Novo Nordisk’s semaglutide, also known as Wegovy, lost an average of 33 pounds.

· 1d

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

· 1d

Here’s how much extra weight is lost with Zepbound over Wegovy

1don MSN

This Drug Is Nearly 50 Percent More Effective Than Wegovy

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

Healio6h

Tirzepatide bests semaglutide for weight loss in adults with obesity

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the SURMOUNT-5 trial. As Healio previously reported,